Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Cost-utility analysis of treatment algorithms for moderate grade vesicoureteral reflux using Markov models.

Hsieh MH, Swana HS, Baskin LS, Meng MV.

J Urol. 2007 Feb;177(2):703-9; discussion 709. Review.

PMID:
17222660
[PubMed - indexed for MEDLINE]
2.

Parental preferences in the management of vesicoureteral reflux.

Ogan K, Pohl HG, Carlson D, Belman AB, Rushton HG.

J Urol. 2001 Jul;166(1):240-3.

PMID:
11435878
[PubMed - indexed for MEDLINE]
3.

What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years.

Lorenzo AJ, Pippi Salle JL, Barroso U, Cook A, Grober E, Wallis MC, Bägli DJ, Khoury AE.

J Urol. 2006 Oct;176(4 Pt 2):1851-5.

PMID:
16945671
[PubMed - indexed for MEDLINE]
4.

Outcomes and cost analysis of pyeloplasty for antenatally diagnosed ureteropelvic junction obstruction using Markov models.

Hsieh MH, Meng MV, Baskin LS.

Urology. 2008 Oct;72(4):794-9. doi: 10.1016/j.urology.2007.12.093. Epub 2008 Jul 31.

PMID:
18674802
[PubMed - indexed for MEDLINE]
5.

The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 2. Reflux correction at the time of diagnosis as a substitute for traditional management.

Benoit RM, Peele PB, Cannon GM Jr, Docimo SG.

J Urol. 2006 Dec;176(6 Pt 1):2649-53; discussion 2653.

PMID:
17085183
[PubMed - indexed for MEDLINE]
6.

The effect of dysfunctional voiding on the costs of treating vesicoureteral reflux: a computer model.

Benoit RM, Wise BV, Naslund MJ, Mathews R, Docimo SG.

J Urol. 2002 Nov;168(5):2173-6; discussion 2176.

PMID:
12394753
[PubMed - indexed for MEDLINE]
7.

Cross-sectional evaluation of parental decision making factors for vesicoureteral reflux management in children.

Hsieh MH, Madden-Fuentes RJ, Bayne A, Munch E, Wildenfels P, Alexander SJ, Gonzales ET Jr, Cisek LJ, Jones EA, Roth DR.

J Urol. 2010 Oct;184(4 Suppl):1589-93. doi: 10.1016/j.juro.2010.03.083. Epub 2010 Aug 21.

PMID:
20728107
[PubMed - indexed for MEDLINE]
8.

Role of periureteral injections in children with vesicoureteral reflux.

Keating MA.

Curr Opin Urol. 2005 Nov;15(6):369-73. Review.

PMID:
16205485
[PubMed - indexed for MEDLINE]
9.

Cost analysis of the treatment of vesicoureteral reflux: a computer model.

Mathews R, Naslund M, Docimo S.

J Urol. 2000 Feb;163(2):561-6; discussion 566-7. Review.

PMID:
10647685
[PubMed - indexed for MEDLINE]
10.

The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.

Benoit RM, Peele PB, Docimo SG.

J Urol. 2006 Oct;176(4 Pt 1):1588-92; discussion 1592.

PMID:
16952694
[PubMed - indexed for MEDLINE]
11.

Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.

Cerwinka WH, Scherz HC, Kirsch AJ.

J Urol. 2007 Oct;178(4 Pt 1):1469-73. Epub 2007 Aug 16.

PMID:
17706704
[PubMed - indexed for MEDLINE]
12.

Reference ranges for cystographic bladder capacity in children-with special attention to vesicoureteral reflux.

Bael AM, Lax H, Hirche H, Hjälms K, Tamminen-Möbius T, Van Hoeck KM, van Gool JD; International Reflux Study in Children.

J Urol. 2006 Oct;176(4 Pt 1):1596-600.

PMID:
16952697
[PubMed - indexed for MEDLINE]
13.

Endoscopic treatment of vesicoureteral reflux with collagen: preliminary report and cost analysis.

Leonard MP, Decter A, Mix LW, Johnson HW, Coleman GU.

J Urol. 1996 May;155(5):1716-20.

PMID:
8627868
[PubMed - indexed for MEDLINE]
14.

Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.

Puri P, Mohanan N, Menezes M, Colhoun E.

J Urol. 2007 Oct;178(4 Pt 2):1714-6; discussion 1717. Epub 2007 Aug 17.

PMID:
17707016
[PubMed - indexed for MEDLINE]
15.

Vesicoureteral reflux and ureteroceles.

Pohl HG, Joyce GF, Wise M, Cilento BG Jr.

J Urol. 2007 May;177(5):1659-66.

PMID:
17437779
[PubMed - indexed for MEDLINE]
16.

Role of prophylaxis in vesicoureteral reflux.

Faust WC, Pohl HG.

Curr Opin Urol. 2007 Jul;17(4):252-6. Review.

PMID:
17558268
[PubMed - indexed for MEDLINE]
17.

Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.

Ashley R, Vandersteen D.

J Urol. 2008 Oct;180(4 Suppl):1611-3; discussion 1614. doi: 10.1016/j.juro.2008.04.084. Epub 2008 Aug 16.

PMID:
18710741
[PubMed - indexed for MEDLINE]
18.

New contralateral vesicoureteral reflux after endoscopic correction of unilateral reflux--is routine contralateral injection indicated at initial treatment?

Menezes M, Mohanan N, Haroun J, Colhoun E, Puri P.

J Urol. 2007 Oct;178(4 Pt 2):1711-3. Epub 2007 Aug 17.

PMID:
17707017
[PubMed - indexed for MEDLINE]
19.

Vesicoscopic cross-trigonal ureteral reimplantation: a minimally invasive option for repair of vesicoureteral reflux.

Canon SJ, Jayanthi VR, Patel AS.

J Urol. 2007 Jul;178(1):269-73; discussion 273. Epub 2007 May 17.

PMID:
17499791
[PubMed - indexed for MEDLINE]
20.

Computational model for predicting the chance of early resolution in children with vesicoureteral reflux.

Knudson MJ, Austin JC, Wald M, Makhlouf AA, Niederberger CS, Cooper CS.

J Urol. 2007 Oct;178(4 Pt 2):1824-7. Epub 2007 Aug 17.

PMID:
17707424
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk